全部

1·ConclusionTA is effective and safe for diabetic macular edema.

结论曲安奈德治疗糖尿病性黄斑水肿安全有效。

2·OCT of diabetic macular edema in the early diagnosis is of great significance.

OCT对糖尿病黄斑水肿的早期诊断具有重要意义。

3·Objective Compare the results of argon and krypton laser photocoagulation in treatment of diabetic macular edema.

目的分析对比氩激光和氪激光治疗糖尿病性黄斑水肿的疗效。

4·Slit lamp microscope and fundus fluorescein angiography redounded to diagnosis and classification of diabetic macular edema.

裂隙灯视网膜检查和荧光素眼底血管造影检查有助于黄斑水肿的诊断和分型。

5·A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).

一项随机试验来评估治疗对糖尿病性黄斑水肿激光功能及结构的影响（的lucidate研究）。

6·On fluorescein angiography, diabetic macular edema appears to be caused by leakage mainly from micro - aneurysms and short dilated capillary segments.

在荧光素眼底血管造影中发现，导致黄斑水肿的渗漏主要来源于微动脉瘤和扩张的毛细血管。

7·Objective To investigate the effect of retrobulbar injection of triamcinolone acetonide (TA) combined with laser photocoagulation treatment on diffused diabetic macular edema.

目的观察球后注射曲安奈德（TA）联合激光光凝治疗糖尿病性弥漫性黄斑水肿的疗效。

8·METHODS: Diagnostic and typing criterion of diabetic macular edema were established according to findings of retina determined with slit lamp mircoscope and of fundus fluorescein angiography(FFA).

方法： 根据裂隙灯视网膜检查和荧光素眼底血管造影确定糖尿病性黄斑水肿， 进行诊断和分型标准。

9·Objective: to investigate the therapeutic effect of modified grid laser photocoagulation (MGLP) for the treatment of macular edema associated with non - proliferative diabetic retinopathy (NPDR).

目的：探讨改良格栅样光凝在治疗非增殖型糖尿病视网膜病变黄斑水肿中的疗效。